1. Home
  2. CSGP vs ROIV Comparison

CSGP vs ROIV Comparison

Compare CSGP & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CoStar Group Inc.

CSGP

CoStar Group Inc.

HOLD

Current Price

$33.58

Market Cap

21.1B

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$27.61

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSGP
ROIV
Founded
1987
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.1B
20.7B
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
CSGP
ROIV
Price
$33.58
$27.61
Analyst Decision
Buy
Strong Buy
Analyst Count
14
9
Target Price
$67.00
$28.94
AVG Volume (30 Days)
5.3M
4.5M
Earning Date
04-28-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$965,230,000.00
$29,053,000.00
Revenue This Year
$19.71
N/A
Revenue Next Year
$12.40
$744.61
P/E Ratio
$1,799.00
N/A
Revenue Growth
15.23
N/A
52 Week Low
$34.75
$10.58
52 Week High
$97.43
$30.33

Technical Indicators

Market Signals
Indicator
CSGP
ROIV
Relative Strength Index (RSI) 26.06 44.20
Support Level N/A $26.94
Resistance Level $41.03 $27.94
Average True Range (ATR) 1.73 0.87
MACD -0.14 -0.20
Stochastic Oscillator 5.77 16.35

Price Performance

Historical Comparison
CSGP
ROIV

About CSGP CoStar Group Inc.

CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors spanning office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many well-respected brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence into Canada, the United Kingdom, Spain, and France.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: